Literature DB >> 17288958

[The superior vena cava as a site of ectopic foci in atrial fibrillation].

Agustín Pastor1, Ambrosio Núñez, Ana Magalhaes, Paula Awamleh, Francisco García-Cosío.   

Abstract

Radiofrequency catheter ablation of ectopic foci that trigger atrial fibrillation has been established as a curative method for patients with symptomatic paroxysmal atrial fibrillation. Although the majority of these foci are located in and around the pulmonary veins, other less common locations have been identified. Recognition that foci can lie outside the pulmonary veins is important for ensuring therapeutic success. The most frequently reported foci of ectopic activity outside the pulmonary veins are in the superior vena cava and the posterior wall of the left atrium. Here we report our experience with the ablation of ectopic foci located in the superior vena cava in patients with symptomatic paroxysmal atrial fibrillation.

Entities:  

Mesh:

Year:  2007        PMID: 17288958

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  3 in total

1.  Successful use of "cryo-mapping" to avoid phrenic nerve damage during ostial superior vena caval ablation despite nerve proximity.

Authors:  Chadi Dib; Suraj Kapa; Brian D Powell; Douglas L Packer; Samuel J Asirvatham
Journal:  J Interv Card Electrophysiol       Date:  2008-03-07       Impact factor: 1.900

Review 2.  Recent advances in rhythm control for atrial fibrillation.

Authors:  Richard Bond; Brian Olshansky; Paulus Kirchhof
Journal:  F1000Res       Date:  2017-10-03

Review 3.  Atrial Fibrillation Mechanisms and Implications for Catheter Ablation.

Authors:  Ghassen Cheniti; Konstantinos Vlachos; Thomas Pambrun; Darren Hooks; Antonio Frontera; Masateru Takigawa; Felix Bourier; Takeshi Kitamura; Anna Lam; Claire Martin; Carole Dumas-Pommier; Stephane Puyo; Xavier Pillois; Josselin Duchateau; Nicolas Klotz; Arnaud Denis; Nicolas Derval; Pierre Jais; Hubert Cochet; Meleze Hocini; Michel Haissaguerre; Frederic Sacher
Journal:  Front Physiol       Date:  2018-10-17       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.